Literature DB >> 19710618

Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report.

Elizabeth M O'Brien1, Peter B Rosenquist, James N Kimball, Gregory N Dunn, Bryan Smith, Lorraine M Arias.   

Abstract

Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an alpha2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19710618     DOI: 10.1097/YCT.0b013e3181b07c26

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  3 in total

1.  Successful treatment of acute mania and perineal abscess using dexmedetomidine sedation as adjunctive therapy.

Authors:  Adam L Ackerman; Cristin Mount
Journal:  BMJ Case Rep       Date:  2011-10-04

2.  Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia.

Authors:  Suna Su Aksay; Jan Malte Bumb; Dmitry Remennik; Manfred Thiel; Laura Kranaster; Alexander Sartorius; Christoph Janke
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-23       Impact factor: 2.570

3.  Amlodipine and the Successful Management of Post-Electroconvulsive Therapy Agitation.

Authors:  Ali Shahriari; Maryam Khooshideh; Mahdi Sheikh
Journal:  Case Rep Psychiatry       Date:  2016-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.